Federated Hermes’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Buy
135,263
+20,127
+17% +$251K ﹤0.01% 1032
2025
Q4
$1.49M Buy
115,136
+9,714
+9% +$125K ﹤0.01% 1023
2025
Q3
$1.36M Sell
105,422
-17,650
-14% -$236K ﹤0.01% 1049
2025
Q2
$2.19M Sell
123,072
-97,003
-44% -$1.69M ﹤0.01% 919
2025
Q1
$3.92M Sell
220,075
-687,912
-76% -$15.6M 0.01% 772
2024
Q4
$27.1M Sell
907,987
-89,457
-9% -$1.89M 0.06% 348
2024
Q3
$15.6M Buy
997,444
+254,517
+34% +$4.61M 0.03% 478
2024
Q2
$12.7M Buy
742,927
+40,870
+6% +$719K 0.03% 491
2024
Q1
$11M Buy
702,057
+85,265
+14% +$1.25M 0.03% 550
2023
Q4
$9.21M Buy
616,792
+548,852
+808% +$7.35M 0.02% 573
2023
Q3
$1.1M Buy
+67,940
New +$1.96M ﹤0.01% 1084
2022
Q3
Sell
-85
Closed -$6K 2212
2022
Q2
$6K Buy
+85
New +$6.4K ﹤0.01% 1880
2021
Q2
Sell
-71,825
Closed -$9.49M 2291
2021
Q1
$9.49M Sell
71,825
-23,797
-25% -$3.76M 0.02% 676
2020
Q4
$16.5M Buy
95,622
+29,774
+45% +$4.07M 0.03% 517
2020
Q3
$7.33M Buy
+65,848
New +$5.27M 0.02% 648
2020
Q1
Sell
-7,599
Closed -$640K 2322
2019
Q4
$640K Sell
7,599
-108,542
-93% -$8.76M ﹤0.01% 1401
2019
Q3
$8.69M Buy
116,141
+114,773
+8,390% +$9.18M 0.02% 611
2019
Q2
$86K Sell
1,368
-57,494
-98% -$2.91M ﹤0.01% 1625
2019
Q1
$2.83M Buy
58,862
+58,846
+367,788% +$2.83M 0.01% 934
2018
Q4
$1K Sell
16
-179,421
-100% -$6.56M ﹤0.01% 2135
2018
Q3
$9.4M Buy
179,437
+58,319
+48% +$2.32M 0.02% 593
2018
Q2
$3.79M Buy
121,118
+121,068
+242,136% +$3.37M 0.01% 772
2018
Q1
$1K Sell
50
-46
-48% -$989 ﹤0.01% 2111
2017
Q4
$2K Sell
96
-9
-9% -$173 ﹤0.01% 2080
2017
Q3
$2K Sell
105
-8
-7% -$157 ﹤0.01% 2050
2017
Q2
$2K Buy
+113
New +$1.46K ﹤0.01% 2045
2017
Q1
Sell
-50,000
Closed -$393K 2168
2016
Q4
$393K Hold
50,000
﹤0.01% 1378
2016
Q3
$427K Hold
50,000
﹤0.01% 1328
2016
Q2
$584K Hold
50,000
﹤0.01% 1241
2016
Q1
$724K Buy
50,000
+20,000
+67% +$287K ﹤0.01% 1181
2015
Q4
$671K Buy
+30,000
New +$717K ﹤0.01% 1209

Other funds holding NVCR